US55028X1090 - LUMO - A2P12E (XNAS)
LUMOS PHARMA INC Acción
4,35 USD
Cotizaciones actuales de LUMOS PHARMA INC
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria | Variación diaria % |
---|---|---|---|---|---|---|
NASDAQ |
LUMO
|
USD
|
11.12.2024 21:59
|
4,35 USD
| 4,34 USD | 0,23 % |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,00 % | 0,00 % | 0,93 % | 8,48 % | 94,20 % | 43,09 % | 86,70 % |
Company Profile for LUMOS PHARMA INC Share
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.
Company Data for LUMOS PHARMA INC Share
Name LUMOS PHARMA INC
Company Lumos Pharma, Inc.
Symbol LUMO
Website https://www.lumos-pharma.com
Primary Exchange
NASDAQ
WKN A2P12E
ISIN US55028X1090
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Richard J. Hawkins
Market Capitalization 32 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 4200 Marathon Boulevard, 78756 Austin
IPO Date 2011-11-11
Stock Splits
Date | Split |
---|---|
19.03.2020 | 1:9 |
ID Changes
Date | From | To |
---|---|---|
19.03.2020 | NLNK | LUMO |
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | LUMO |
More Shares
Investors who LUMOS PHARMA INC hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.